Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41

Science. 1996 Dec 13;274(5294):1917-21. doi: 10.1126/science.274.5294.1917.

Abstract

Indirect mechanisms are implicated in the pathogenesis of the dementia associated with human immunodeficiency virus-type 1 (HIV-1) infection. Proinflammatory molecules such as tumor necrosis factor alpha and eicosanoids are elevated in the central nervous system of patients with HIV-1-related dementia. Nitric oxide (NO) is a potential mediator of neuronal injury, because cytokines may activate the immunologic (type II) isoform of NO synthase (iNOS). The levels of iNOS in severe HIV-1-associated dementia coincided with increased expression of the HIV-1 coat protein gp41. Furthermore, gp41 induced iNOS in primary cultures of mixed rat neuronal and glial cells and killed neurons through a NO-dependent mechanism. Thus, gp41-induced NO formation may contribute to the severe cognitive dysfunction associated with HIV-1 infection.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • AIDS Dementia Complex / enzymology*
  • AIDS Dementia Complex / metabolism
  • Animals
  • Brain / enzymology*
  • Brain / metabolism
  • Cell Death
  • Cells, Cultured
  • Cerebral Cortex / enzymology
  • Cerebral Cortex / metabolism
  • Enzyme Induction
  • HIV Envelope Protein gp120 / metabolism
  • HIV Envelope Protein gp120 / pharmacology
  • HIV Envelope Protein gp41 / metabolism*
  • HIV Envelope Protein gp41 / pharmacology
  • HIV-1*
  • Humans
  • Neuroglia / cytology
  • Neurons / cytology
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase / biosynthesis*
  • Nitric Oxide Synthase / genetics
  • Polymerase Chain Reaction
  • Rats

Substances

  • HIV Envelope Protein gp120
  • HIV Envelope Protein gp41
  • Nitric Oxide
  • Nitric Oxide Synthase